Diffusion Weighted Imaging in Prostate Cancer

Similar documents
11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Imaging of prostate cancer local recurrences : why and how?

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

Abdominal applications of DWI

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Prostate MRI for local staging and surgical planning in prostate cancer

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???

Genitourinary Imaging Original Research

Prostate Cancer DFP Case of the Week

Optimizing Implementation of Prostate MRI. Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department

OASIS 1.2T: MULTIPARAMETRIC MRI OF PROSTATE CANCER

Stephen McManus, MD David Levi, MD

Prostate MRI: Who needs it?

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging

PI-RADS V2 IN PRACTICE A PICTORIAL REVIEW

Prostate MRI: Not So Difficult. Neil M. Rofsky, MD, FACR, FSCBTMR, FISMRM Dallas, TX

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

The diagnosis and localization of prostate cancer are based on a digital

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination

ADRENAL MR: PEARLS AND PITFALLS

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71 (2), Page

Current Clinical Practice. MR Imaging Evaluations. MRI Anatomic Review. Imaging to Address Clinical Challenges. Prostate MR

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin.

Multiparametric MRI diagnostic value in a case of prostate cancer

The Role of Combined MRI & MRSI in Treating Prostate Cancer

Improved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template

Utility of Prostate MRI. John R. Leyendecker, MD

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Diffusion Weighted Imaging in IBD: An Update Ethan A. Smith, MD

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors

Prostate MRI: Access to and Current Practice of Prostate MRI in the United States

Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T

Anatomic Imaging of Prostate Cancer

Interac(ve Experience with Prostate Imaging Repor(ng and Data System Version 2 (PI-RADS v2)

Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer

Prostate Case Scenario 1

Genitourinary Imaging Original Research

Essential Initial Activities and Clinical Outcomes

Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.

Diffusion weighted imaging in prostate cancer

Contrast-enhanced Breast MRI RSSA 2013

Int J Clin Exp Med 2016;9(2): /ISSN: /IJCEM Dong Yang 1, Nan Jin 2, Yan Guo 3, Huan-Jun Wang 3, Bi-Tao Pan 3

What Radiologists do?

Multiparametric Prostate MRI: PI-RADS V.2

MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI

Prostate Cancer: Comparison of Tumor Visibility on Trace Diffusion- Weighted Images and the Apparent Diffusion Coefficient Map

The follow-up of uterine fibroids treated with HIFU: role of DWI and Dynamic contrast-study MRI

MRI and Fusion biopsies. K Sahadevan Consultant Urologist

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)

Can Diffusion-Weighted Magnetic Resonance Imaging Predict a High Gleason Score of Prostate Cancer?

The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses

PI-RADS version 2 - what we need to know

Diffusion-Weighted Magnetic Resonance Imaging Detects Local Recurrence After Radical Prostatectomy: Initial Experience

Innovations in HCC Imaging: MDCT/MRI

MOLECULAR MEDICINE REPORTS 9: , Provincial Hospital, Shandong University, Jinan , P.R. China

Localized at a focus, central point or locus. Localized finding distinct from neighboring tissues, not a threedimensional

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre

Correlated diffusion imaging

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Functional MRI in Oncology

Differentiation of Noncancerous Tissue and Cancer Lesions by Apparent Diffusion Coefficient Values in Transition and Peripheral Zones of the Prostate

Standards for MRI reporting the evolution to PI-RADS v 2.0

MRI/MRS Biomarkers. Robert E. Lenkinski, Ph.D.

Genitourinary Imaging Original Research

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Interesting case. Vikas Kundra, M.D., Ph.D. October Vikas Kundra, M.D., Ph.D.

HHS Public Access Author manuscript Abdom Radiol (NY). Author manuscript; available in PMC 2017 January 19.

Genitourinary Imaging Original Research

Prostate Cancer Imaging: most common pitfalls in multiparametric Magnetic Resonance

Research Article Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

Department of Urology, II Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey 2

T2, T2*, ute. Yeo Ju Kim. Radiology, Inha University Hospital, Incheon, Korea

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Prostate Overview Quiz

Successful Breast MRI Program : The ingredients

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Shayan Sirat Maheen Anwar, 1 Zahid Anwar Khan, 2 Rana Shoaib Hamid, 3 Fahd Haroon, 4 Raza Sayani, 1 Madiha Beg, 1 and Yasir Jamil Khattak 1

بسم هللا الرحمن الرحيم. Prof soha Talaat

ESUR 2018, Sept. 13 th.-16 th., 2018 Barcelona, Spain

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Role of MRI in the diagnosis and management of prostate cancer

Prostate Cancer 3/15/2017. CEUS of the Prostate. The Prostate Cancer Screening Dilemma Data. Incidence: 161,360 Deaths: 26,730

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

Additional value of Diffusion Weighted Imaging in the detection and treatment of prostate cancer

Staging Colorectal Cancer

The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Multiparametric 3T MR imaging of the prostate - acquisition protocols and image evaluation

Osher Mini Medical School for the Public

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management

Prostate Cancer Imaging :What the Urologist Needs to Know

Prostate Imaging An Update.. Mayfair Diagnostics Presentation for Prostaid Calgary March 12, 2019

Transcription:

Diffusion Weighted Imaging in Prostate Cancer

Disclosure Information Vikas Kundra, M.D, Ph.D. No financial relationships to disclose.

Education Goals and Objectives To describe the utility of diffusion-weighted imaging in localizing cancer involving the prostate gland.

T2 Prostate Carcinoma T2 T1

DWI basic principal In vitro: Free diffusion secondary to constant Brownian motion. In tissues: Restricted diffusion- affected by factors such as vascularity, cellularity and membrane integrity.

DWI basic principal In vitro: Free diffusion secondary to constant Brownian motion. In tissues: Restricted diffusion- affected by factors such as vascularity, cellularity and membrane integrity.

DWI basic principal Static water molecules Moving water molecules Blood vessels Signal 50 Extracellular space - cysts, gallbladder, etc Intracellular space Extracellular space- hypercellular tissue b values

Signal Faster/longer motion (macro) Blood vessels 50 Cellular level diffusion Extracellular space - cysts, gallbladder, etc b values Intracellular space Extracellular space- hypercellular tissue

Effect of b o value b o = 1000 b o = 700 b o = 500 b o = 300 D W I A D C

Diffusion-weighted Imaging T2 ADC

Tumors can have heterogeneous ADC, and can look dark on DWI due to T2-shine through T1 T2 DWI ADC

Studies Using DWI Imaging Various techniques & ADC cutoff Kim et al JCAT 2007 De Souza et al Brit J. Rad 2007 Magnet Coil bo Th mm 3T Phased array 0, 1000 1.5T ERC 0, 300, 500, 800 4 35 P Z n ADC CA ADC B9 T Z 4 30 P Z T Z ADC cutoff Sens Spec 1.32 1.97 1.67 94 91 1.37 1.79 1.61 90 84 1.3 1.71 1.6 87 72 Reinsberger 1.5T ERC 0, 300, 4 42 P 1.19 1.51 1.26 et al AJR 500, Z ADC 2007 800 >30% in voxel 67 >70% in voxel 93 MRS >30% in voxel 81 >70% in voxel 93 T 1.31 Amount of pathology in voxel influences Z detectability Miao et al. Eur J of Rad 2007 Tanimoto et al JMRI 2007 3T Phased Array 0, 300, 600 1.5T ERC 0, 1000 5 37 visual DWI T2 5 83 P Z visual T2 T2+DWI T2+DWI+DCE Visual imaging rather than ADC cutoffs may be helpful 1.46 84 75 73 84 95 60 57 64 73 81 73 54 85 74

More Recent Studies Have Reported Similar Sensitivities and Specificities for DWI alone and Suggest DWI adds to Sensitivity and Specificity of T2-weighted imaging Sensitivity (%) Specificity (%) N (pts) Article T2 51 61 37 Yoshimitsu, JMRI 2008 T2/DWI 71 61 T2 77 66 29 Ren, Eur, Radio 2009 T2/DWI 87 83 T2 74/67/67 79/77/57 52 Lim, Radiology 2009 T2/DWI 88/81/78 88/89/63-3 readers T2 73 65 68 Ren, JMRI 2009 T2/DWI 82 78

Gleason 3+3 not initially seen, in retrospect can be seen at apex T1 T2 DWI ADC

DWI imaging can identify prostate cancer in the Central Zone, but sensitivity is lower in the CZ and cut-off values may be lower (Kim JMRI 2008) Zone Sequence Sensitivity (%) Specificity (%) N (pts) Article PZ T2 57 80 51 Haider, AJR 2007 PZ T2/DWI 87 91 51 CZ T2 36 90 51 Haider, AJR 2007 CZ T2/DWI 41 92 51 PZ, ADC 1.28 DWI 98 81 47 Kim JH, JMRI 2008 CZ, ADC DWI 81 87 47 1.11 CZ T2 13 8 Shimofusa, 2005 CZ DWI 63 8

Central Zone Tumors are often Missed by Imaging

BPH can have low ADC DWI ADC

Diffuse Prostate Cancer in PZ inseparable from CZ T2 DWI ADC

DW Imaging may Identify Invasion into Adjacent Organs Seminal Vesicle Invasion Sequence Sensitivity (%) Specificity (%) N (pts) Article SV T2 77 66 29 Ren, Eur Rad 2009 SV DWI 80 71 29 SV T2/DWI 87 83 29 SV, reader 1,2 T2 87,57 87,81 30 Kim CK, JMRI 2008 SV, reader 1,2 T2/DWI 93,67 97,96 30

DW imaging may identify urinary bladder neck invasion Ren et al (JMRI 2009) reported ADC values for urinary bladder invasion of 0.963 + 0.155 x 10 3 mm 2 /sec vs 1.517 + 0.103 x 10 3 mm 2 /sec for normal urinary bladder wall (P < 0.001). AUC for T2-weighted imaging plus DW imaging (0.861) was larger than that for T2-weighted imaging alone (0.734) or for DW imaging alone (0.703) (P < 0.001).

Seminal Vesicle Invasion T2 DWI ADC

DW Imaging Confounding Factors Benign conditions (Xu et al Magn Res Med 2009) BPH Prostatitis Susceptibility artifact (Riches et al NMR Biomed 2009) Tissue boundaries Blood Increased vascular flow within the tumor (Van et al Br J Radio 2008) Motion (Lim et al Radiology 2009) Well differentiated tumor (Yoshimitsu et al JMRI 2008)

Diffusion-weighted Imaging - Hemorrhage can cause susceptibility artifact T1 T2 ADC

DWI-Hemorrhage can cause susceptibility artifact T1 Blood DWI T2 Tumor T2 ADC ADC

Hemorrhage resulted in difficulty identifying tumor, but seen on ADC at apex T1 T2 DWI ADC

DWI vs Other Functional Modalities (DCE-MR or MRS) Results have been mixed Whether one modality is better Whether combining with other functional modalities improves sensitivity and specificity Chen et al. Acta Radiol. 2008 Reinsberg SA AJR Am J Roentgenol. 2007 Mazaheri Y Radiology. 2008 Kim CK Abdom Imaging. 2009 Kim CK AJR 2008 Tamada T Radiology. 2008

DWI can identify Lymph Nodes Small FOV Large FOV

DW Imaging Potential Clinical Impact DWI imaging may Improve tumor localization in patients with a prior failed biopsy, but elevated PSA (3T, T2+DWI sensitivity 54-81% vs 81-84% T2 only (Park et al. Invest Radiol. 2008) Aid guiding biopsy in patient with failed prior biopsy, but elevated PSA Tumor localization for radiation therapy planning, especially for finer spatial resolution therapies such as proton beam therapy

DW Imaging Potential Clinical Impact DWI imaging may Aide tumor localization in areas of hemorrhage (DiBiase et al Int J Radiat Oncol Biol Phys 2002) Improve tumor staging Such as invasion into adjacent structures Potentially identifies tumors of higher grade (DeSouza et al. Clin Radiol. 2008) Detect Recurrence following therapy such as External beam radiation (Kim CK, Abdominal Imaging 2009) High frequency ultrasound (Kim CK, AJR 2008)

Thank you